[go: up one dir, main page]

MX2022001764A - Composiciones que comprenden tigolaner para el control de parasitos. - Google Patents

Composiciones que comprenden tigolaner para el control de parasitos.

Info

Publication number
MX2022001764A
MX2022001764A MX2022001764A MX2022001764A MX2022001764A MX 2022001764 A MX2022001764 A MX 2022001764A MX 2022001764 A MX2022001764 A MX 2022001764A MX 2022001764 A MX2022001764 A MX 2022001764A MX 2022001764 A MX2022001764 A MX 2022001764A
Authority
MX
Mexico
Prior art keywords
tigolaner
parasites
control
compositions including
medicament
Prior art date
Application number
MX2022001764A
Other languages
English (en)
Inventor
Iris Heep
Elisabeth Feldhues
Venkata-Rangarao Kanikanti
Gabriele Petry
David Siegel
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of MX2022001764A publication Critical patent/MX2022001764A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende tigolaner y, opcionalmente, agentes endoparasiticidas, un método para su fabricación y su uso como un medicamento para el control de parásitos.
MX2022001764A 2019-08-14 2020-08-12 Composiciones que comprenden tigolaner para el control de parasitos. MX2022001764A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19191727 2019-08-14
PCT/EP2020/072640 WO2021028479A1 (en) 2019-08-14 2020-08-12 Compositions comprising tigolaner for controlling parasites

Publications (1)

Publication Number Publication Date
MX2022001764A true MX2022001764A (es) 2022-08-04

Family

ID=67658818

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022001764A MX2022001764A (es) 2019-08-14 2020-08-12 Composiciones que comprenden tigolaner para el control de parasitos.

Country Status (21)

Country Link
US (2) US12502390B2 (es)
EP (1) EP4013388A1 (es)
JP (1) JP7596359B2 (es)
KR (1) KR20220054319A (es)
CN (2) CN120478592A (es)
AU (1) AU2020328863B2 (es)
BR (1) BR112022002623A2 (es)
CA (1) CA3147171A1 (es)
CO (1) CO2022002898A2 (es)
CR (1) CR20220112A (es)
DO (1) DOP2022000035A (es)
EC (1) ECSP22012650A (es)
IL (1) IL290597A (es)
MX (1) MX2022001764A (es)
NZ (1) NZ785805A (es)
PH (1) PH12022550328A1 (es)
TW (1) TWI861178B (es)
UA (1) UA128873C2 (es)
UY (1) UY38841A (es)
WO (1) WO2021028479A1 (es)
ZA (1) ZA202202672B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4013388A1 (en) 2019-08-14 2022-06-22 Vetoquinol SA Compositions comprising tigolaner for controlling parasites
CR20220665A (es) 2020-05-29 2023-07-19 Boehringer Ingelheim Pharma Compuestos heterocíclicos como anthelmínticos
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105065A1 (en) * 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105064A1 (en) * 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
DK182016B1 (en) 2023-03-13 2025-05-28 Zoetis Services Llc Degradation of isoxazolines in ozonated sea water

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331414T2 (de) 1992-03-17 2002-08-08 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide, herstellung und anwendung
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
AU2003231473A1 (en) 2002-06-26 2004-01-19 Kiyoshi Otsuka Method for producing hydrogen and apparatus for supplying hydrogen
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE102004020721A1 (de) 2004-04-28 2005-11-24 Bayer Healthcare Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006061538A1 (de) 2006-12-27 2008-07-03 Bayer Healthcare Ag Kombinationsprodukt zur Bekämpfung von Parasiten an Tieren
UA108641C2 (uk) * 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
KR102044202B1 (ko) 2012-07-19 2019-11-13 바이엘 애니멀 헬스 게엠베하 5-플루오로-1h-피라졸의 제조 방법
WO2014122083A1 (de) 2013-02-06 2014-08-14 Bayer Cropscience Ag Halogensubstituierte pyrazolderivate als schädlingsbekämpfungsmittel
EP3083565B1 (en) 2013-11-27 2020-12-23 Bayer Animal Health GmbH Process for the preparation of 5-fluoro-1h-pyrazoles
US9725415B2 (en) 2013-11-27 2017-08-08 Bayer Cropscience Aktiengesellschaft Process for the preparation of 5-fluoro-1H-pyrazoles
EP3126334A1 (en) 2014-04-01 2017-02-08 Bayer CropScience Aktiengesellschaft Process for the preparation of n-[3-(benzylcarbamoyl)phenyl]-1 h-pyrazole-5-carboxamides
TWI694066B (zh) 2014-05-27 2020-05-21 德商拜耳動物保健有限公司 始於六氟丙烯之製備５-氟-１ｈ-吡唑的方法
SI3183237T1 (sl) 2014-08-19 2020-01-31 Bayer Animal Health Gmbh Postopek za pripravo 5-fluoro-1H-pirazolov z začetkom iz heksafluoropropena
WO2016174049A1 (en) 2015-04-30 2016-11-03 Bayer Animal Health Gmbh Anti-parasitic combinations including halogen-substituted compounds
BR112017023662B1 (pt) 2015-05-05 2022-06-07 Syngenta Participations Ag Método de controle e/ou prevenção de infestação de percevejos, uso de um composto e método para cultivar soja
AR104691A1 (es) 2016-05-18 2017-08-09 Labyes De Uruguay S A Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros
CA3074620A1 (en) * 2017-09-06 2019-03-14 Bayer Animal Health Gmbh Topically administrable formulation for the control and prevention of animal parasites
JP2019094270A (ja) 2017-11-17 2019-06-20 日産化学株式会社 有害生物防除用組成物及び有害生物の防除方法
EP4013388A1 (en) 2019-08-14 2022-06-22 Vetoquinol SA Compositions comprising tigolaner for controlling parasites

Also Published As

Publication number Publication date
WO2021028479A1 (en) 2021-02-18
PH12022550328A1 (en) 2023-02-06
TWI861178B (zh) 2024-11-11
JP2022544537A (ja) 2022-10-19
UY38841A (es) 2021-02-26
KR20220054319A (ko) 2022-05-02
AU2020328863B2 (en) 2025-10-23
TW202122079A (zh) 2021-06-16
CN114698369A (zh) 2022-07-01
ZA202202672B (en) 2023-05-31
CA3147171A1 (en) 2021-02-18
CR20220112A (es) 2022-06-21
UA128873C2 (uk) 2024-11-13
JP7596359B2 (ja) 2024-12-09
ECSP22012650A (es) 2022-03-31
AU2020328863A1 (en) 2022-04-07
EP4013388A1 (en) 2022-06-22
NZ785805A (en) 2025-10-31
CN120478592A (zh) 2025-08-15
US20220331314A1 (en) 2022-10-20
CO2022002898A2 (es) 2022-04-19
BR112022002623A2 (pt) 2022-05-03
US12502390B2 (en) 2025-12-23
US20260007662A1 (en) 2026-01-08
DOP2022000035A (es) 2022-05-31
IL290597A (en) 2022-04-01

Similar Documents

Publication Publication Date Title
MX2022001764A (es) Composiciones que comprenden tigolaner para el control de parasitos.
DOP2020000023A (es) Nuevos derivados de quinolina
MX2019005009A (es) 1,2,4-triazolonas 2,4,5-trisustituidas.
CO2019014484A2 (es) Nuevos derivados de azaquinolina
DOP2017000038A (es) 2-(morfolin-4-il)-1,7-naftiridinas
DOP2019000117A (es) Nuevos derivados de quinolina
MX2018012544A (es) Nuevos derivados de pirazolopirimidina.
DOP2019000275A (es) Nuevos derivados de pirazol bicíclicos
UY36619A (es) Amidas cíclicas sustituidas como herbicidas
MX392313B (es) Combinaciones de un derivado de 4-pirimidinsulfamida con ingredientes activos para el tratamiento de enfermedades relacionadas con endotelina.
CO2020013876A2 (es) Nuevos derivados de quinolina
UY36712A (es) Derivados de pirimidiniloxi benceno como herbicidas
MY177933A (en) Herbicidal composition comprising quizalofop-p
CO2018009677A2 (es) Sulfonamidas sustituidas para controlar plagas animales
CL2019002636A1 (es) Agente para el control de enfermedades en plantas.
BR112021012823A2 (pt) Mistura e composição fungicidas, mistura e composição fungicidas sinergísticas, e, método para controlar doença fúngica
AR106221A1 (es) Una composición de toxicidad baja
UY36160A (es) “3-arilpirazoles herbicidas sustituidos”.
UA130333C2 (uk) Композиції, які містять кромогліцієву кислоту, для лікування дерматиту
MX2018008730A (es) Metodos y composiciones para el control de las hormigas cultivadoras de hongos.
CL2016000200A1 (es) Composición para el control enfermedades en plantas, que comprende al menos un compuesto de quinolina y uno o mas fungicidas; métodos para controlar enfermedades en plantas mediante la aplicación de dicha composición.
CL2016000427A1 (es) Composición para el control de enfermedades en plantas que comprende al menos un compuesto de quinola y un fungicida de la familia de las dicarboxilimidas; método para controlar enfermedades en plantas mediante la aplicación de dicha composición
CL2016000429A1 (es) Composición para el control de enfermedades en plantas que comprende al menos un compuesto de quinola y un fungicida de la familia de las bencimidazoles; método para controlar enfermedades en plantas mediante la aplicación de dicha composición
UY37032A (es) Compuestos de heteroarilbenzimidazol
CL2016000196A1 (es) Composición para el control de enfermedades en plantas, que comprende al menos un compuesto de quinolina y uno o más fungicidas; método para controlar enfermedades en plantas mediante la aplicación de dicha composición.